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On a molecular scale, the nucleus is a big place. And, due
to the enormous mass of DNA, RNA, and protein concen-
trated there, the nucleus is far denser than the cytoplasm.
So the question of how various nuclear factors move about
and efficiently find their sites of action has long been a
subject of interest and debate. This biological problem is
complicated by the fact that most such factors function in
large macro-molecular assemblies, with as many as 100
components that must interact at the right time and place.
Relevant to this, many factors, including splicing factors,
are both dispersed through the nucleoplasm and concen-
trated in certain nuclear compartments (Fig. 1). Two re-
cent studies, one in 
 
The
 
 
 
Journal of Cell Biology 
 
(Kruhlak
et al., 2000) and the other in 
 
Nature
 
 (Phair and Misteli,
2000) provide new insights into this fundamental question.
Both studies investigate the nuclear dynamics of green
 
fluorescent protein (GFP)
 
1
 
–labeled proteins, particularly
splicing factor ASF/SF2, in living cells using FRAP (fluo-
rescence recovery after photobleaching) and FLIP (fluo-
rescence loss in photobleaching) to ask the question: how
fast do splicing factors move within the nucleus? The an-
swer to this question is significant for understanding the
mechanisms by which nuclear factors reach their sites of
function. Do the kinetics of factor movement suggest that
they are freely diffusing or constrained by structure, per-
haps actively recruited from one place to the next? Is ASF/
SF2 in the dispersed nucleoplasmic pool, thought to be the
most active fraction, more mobile than in the highly con-
centrated regions frequently considered to be factor stor-
age sites?
 
Do Nuclear Factors Move Quickly or Slowly?
 
Both Kruhlak et al. (2000) and Phair and Misteli (2000)
find that, irrespective of where it is in the nucleus, GFP-
 
ASF/SF2 shows a high degree of mobility, with 
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, it would thus take about a minute to move half-
way across the nucleus and five minutes to equilibrate
throughout. Phair and Misteli (2000) find slightly higher
mobilities for GFP-fibrillarin and the tagged chromatin
protein HMG-17. An important point in both studies is
that GFP alone moves 
 
z
 
100-fold faster than the GFP-
tagged nuclear proteins, so fast that the photobleached
zone could not be photographed before significant re-
covery.
A couple of technical considerations of these experi-
ments merit mention. The presence of higher protein lev-
els, due to expression of exogenous protein, could raise
the apparent mobility of nuclear proteins if endogenous
 
binding sites become saturated as a consequence. As Kruh-
lak et al. (2000) indicate, nucleoplasmic levels of GFP-
ASF often appear higher than in immunofluorescence for
the endogenous splicing factors. The presence of the GFP
tag might also cause an increase in mobility, if it weakens
or disrupts normal interactions. Importantly, GFP-histone
H2B shows very little movement in nuclei (Phair and Mis-
teli, 2000, and references therein), indicating that the GFP
moiety does not confer mobility to just any protein.
Irrespective of any caveats, the two studies apply this
novel approach to obtain convincing and concurring esti-
mates for the mobility rates of the proteins studied. So
given these results, does GFP-ASF/SF2 move quickly or
slowly? Is it diffusing or not? As is often the case, the an-
swer may lie in the eye of the beholder. Both studies make
the important point that there is substantial mobility of
proteins studied, irrespective of the nuclear compartment,
which has further implications discussed below. But de-
spite very similar data, there are notable differences in in-
terpretation and emphasis. Though not necessarily incom-
patible (see below), they evoke long-standing questions as
to the fundamental nature of the nucleoplasm. Kruhlak et
al. (2000) state that movement is much slower than ex-
pected for free diffusion, based on the kinetics of GFP
movement alone. The comparison to GFP is key, as it pro-
vides a baseline for how fast a soluble protein can move
through nuclear viscosity. But the comparison is an imper-
fect one, because proteins differ in their size and charge.
Both studies state that the twofold greater mass of ASF/
SF2 itself would not account for the 100-fold reduction in
mobility. Neither group finds major differences in rates of
movement in transcriptionally inhibited cells, suggesting
that binding to nascent transcripts is not the major factor
in reducing mobility of ASF/SF2. So what accounts for
the reduction in ASF/SF2 movement? Phair and Misteli
(2000) conclude that the rates are consistent with a diffus-
ing protein that is associated with “other components of
 
“nucleoplasmic space,” suggesting that “putative structural
elements” are “insufficient to retard the movement of
studied proteins.” On the other hand, Kruhlak et al. (2000)
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suggest that reduced movement of ASF/SF2 supports its
“frequent but transient association with relatively immo-
bile binding sites.” In their discussion they go further to
suggest that this is evidence of an association with a non-
chromatin, insoluble nuclear matrix or karyoskeleton.
 
Is ASF/SF2 Associated with a Nuclear Matrix?
 
Given the often polarized views on the existence of a nu-
clear matrix, the interpretation by Kruhlak et al. (2000)
will likely be a controversial one. Rather than polarize this
subject further by emphasizing potential differences in in-
terpretation, we offer a perspective that might identify a
common ground. There is a great deal of evidence sup-
porting the existence of insoluble, non-chromatin struc-
tural elements in the nucleus, and some components of
this broadly defined nuclear matrix have indeed been
identified (for example, see Blencowe et al., 1994; Cordes
et al., 1993). This is not to say that the existence of a sys-
tem of long cytoskeletal-like filaments has been proven in
vivo and biochemically characterized. To our understand-
ing, this definition of nuclear matrix as long homopolymer
filaments is more narrow and demanding than that con-
veyed in most papers by leading investigators in this area.
Rather, morphological evidence of short core filaments,
resolvable by electron microscopy, has been presented in
the context of a subcomponent of much more heteroge-
neous fibrillogranular material of the nuclear matrix (for
reviews, see Fey et al., 1991; Stein and Berezney, 1996).
Thus, the nuclear matrix can be conceived of as a dense
meshwork of large macromolecular complexes that may
include not only diverse proteins but RNAs as well, such
as the non-coding XIST RNA involved in X inactivation.
How does this relate to the interpretations and implica-
tions of the recent papers from Hendzel’s and Misteli’s
labs? At some point the large macromolecular complexes
with which ASF/SF2 interacts may associate with each
other or other components of the transcription/processing/
transport machinery to form loose assemblies of com-
plexes so large that they essentially become insoluble ma-
trix structures. Consistent with this concept, members of
the SR family of splicing factors, including ASF/SF2, are
known to interact in a phosphorylation-dependent manner
in vivo (Yeakley et al., 1999, and references therein).
Many, though not necessarily all, of the components in this
lattice-like matrix could be in flux, but the matrix itself
might be relatively immobile. Such a model helps to ex-
plain an apparent paradox concerning the distribution of
splicing factors. Both papers show that the ASF/SF2 con-
centrated in splicing factor domains (the more prominent
speckles) moves at a rate similar to the more dispersed
molecules in the rest of the nucleoplasm. But as is evident
in Kruhlak’s Figure 1 and in previous work (Misteli et al.,
1997), most domains in a cell are relatively immobile.
Thus, while factors within nuclear compartments may be
in flux, the compartment itself is not. This contributes to
the Kruhlak et al. (2000) interpretation that ASF/SF2 as-
sociates with structure.
It has been reported that clusters of factors can move
vectorially from a larger domain, where it has been sug-
gested they are stored, to a gene which was just induced
(Misteli et al., 1997). Such observations might suggest an
active and directed transport of splicing factors, possibly
involving movement along a structure. However, results in
these two papers report that splicing factor movement in
general is neither energy dependent nor affected by phos-
phorylation, even though the latter has been shown to af-
fect their overall distribution (Misteli and Spector, 1996;
Yeakley et al., 1999). Kruhlak et al. (2000) attempt to
study the movement of these tiny subdomains, but con-
clude that movement of such clusters is limited and not
likely to be the major way in which factors find their tar-
gets. Since factors are sufficiently mobile to reach their
targets by a stochastic and non-directed process, there may
be no need for them to move along any kind of structure.
But as Kruhlak et al. (2000) suggest, rather than diffusing
freely, the movement of splicing factors may be con-
strained by frequent transient interactions with structure,
which could still be important to their assembly and/or
function.
Phair and Misteli (2000) discuss that diffusion of splicing
factors may fit with other evidence for (pre)-mRNA
within the nucleus. However, studies of (pre)-mRNA dis-
tribution illustrate the point that random dispersal and
structural constraint are not mutually exclusive alterna-
tives. Again, there is room for common ground. RNA dis-
tributions can vary with the type of RNA and even reflect
different states of the same mRNA within a cell. There is
evidence that some mRNAs randomly disperse (e.g.,
Singh et al., 1999), whereas others appear structurally con-
strained (Fig. 2, B and C; Lawrence et al., 1989; Lampel et
al., 1997), and still others seem structurally constrained at
some steps and more dispersed at others (Fig. 2 A; Xing et
al., 1995). Using fluorescence correlation spectroscopy,
Politz et al. (1998) found evidence that most nuclear poly
A RNA moves at a rate close to diffusion, but that a signif-
icant component moves much more slowly, suggesting it
may be tethered to nuclear structure. These different ob-
servations are not contradictory, but rather reflect com-
plex biological realities. Since FRAP analysis provides
only an average for the population (discussed in Politz,
1998), it remains to be determined if there are also differ-
ent subpopulations of ASF.
Figure 1. Most splicing factors distribute at lower levels through
the nucleoplasm and concentrate in z20–40 distinct domains,
forming a characteristic speckled pattern.  Shown is a human fi-
broblast stained with anti-SC-35, a spliceosome assembly factor
(Yeakley et al., 1999, and references therein). 
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Do Splicing Factor Domains Behave as Stable 
Nuclear Structures?
 
If splicing factors exist in complexes of complexes of many
different factors, at what point can one reasonably con-
clude that they are associated with a structure rather than
macromolecular complexes diffusing in interchromoso-
mal space? As many have suggested before us, a reason-
able point of reference is when non-chromatin factors are
no longer soluble or readily released from the nucleus. Be-
cause of the legitimate concern that salt extraction of un-
fixed cells could precipitate artifacts, a number of experi-
ments reported years ago were designed to address those
concerns for studies of the nuclear matrix in general (for
example, Nickerson et al., 1997; Jackson and Cook, 1985).
Since splicing factor rich domains and nuclear RNAs are
easily visualized by fluorescence microscopy, their associa-
 
tion with structure has been shown by a straightforward
observation that gets too little attention: many RNA meta-
bolic factors, as well as nuclear RNAs, are highly resistant
to extensive detergent extraction (for example, see Carter
et al., 1993, and references therein; Misteli and Spector,
1996). In contrast, cytoplasmic mRNAs (and many pro-
teins) are much more fragile. Future FRAP studies might
do well to include some analysis of simple solubility by this
approach. We have found that even 18 h after detergent
extraction, splicing factor rich domains in unfixed cells are
still very much intact, even when the nucleus itself can be-
come quite disrupted. Recent preliminary observations
show that most factors do not just diffuse away when
unfixed mammalian nuclei are mechanically disrupted
(Shopland, L.S., and J.B. Lawrence, unpublished observa-
tions). Thus, the important finding of ASF/SF2’s mobility
in these domains does not negate the view that these com-
prise structures, consistent with earlier observations that
these regions correspond to structures termed interchro-
matin granule clusters seen by electron microscopy (Fakan
and Puvion, 1980).
A telling comparison is HM6-17 or fibrillarin, both of
which show high mobility but are clearly known to be as-
sociated with structures.
 
How Do Splicing Factor Distributions Relate to 
Gene Expression?
 
The findings of Kruhlak et al., (2000) and Phair and Mis-
teli (2000) leave open the question of why these factors
form 20–40 distinctly higher-concentration domains, and
how this might relate to their function. They find the vast
majority of factors recover at similar average rates in both
the concentrated domains and in the more dispersed nu-
cleoplasmic pool. In our view, this observation is not easily
reconciled with the idea that splicing factor rich domains
contain a higher proportion of inactive factors, which are
then directly recruited to distant sites of function ran-
domly dispersed through the nucleoplasm. It is our per-
spective that an understanding of why and where these
domains form cannot be answered without a detailed
understanding of how nuclear metabolism of specific
genes and RNAs is spatially arranged. Domains rich in
splicing factors and poly A RNA are not randomly ar-
ranged but show a three-dimensional topography that is
consistent for a given cell-type and related to the organiza-
tion of the genome (Carter et al., 1993, and references
therein). The high turnover of factors in domains shown
by these authors fits the idea that factors within domains
are in dynamic use, perhaps in rapid reassembly of com-
plexes closely associated with expression of one or more
highly active, complex genes (Smith et al., 1999; Johnson
et al., 2000). The lower nucleoplasmic levels of factors may
be sufficient for genes whose transcription does not out-
pace splicing (Smith et al., 1999), whereas concentrating
factors in domains may serve to maximize expression of
more demanding genes. This should not be construed to
suggest that these distributions simply reflect the accumu-
lation of dispersed factors on nascent pre-mRNAs of
highly active genes. More consistent with earlier ultra-
structural observations (Fakan and Puvion, 1980), detailed
Figure 2. Reflecting real differences in the complex biology, dis-
tributions of different nuclear RNAs vary from dispersed to
highly localized, or a combination of the two. (A) COL1A1 RNA
shows two very localized accumulations in a diploid fibroblast
nucleus as well as low level dispersed signal, likely representing
individual transcripts. Other work has show that the localized ac-
cumulations are posttranscriptional transcripts emanating to one
side of the gene, hence we refer to them as tracks (Smith et al.,
1999, and references therein; Johnson et al., 2000). (B and C) In
human lymphoma cells, RNA expressed from integrated Epstein
Barr Virus produces a highly elongated curvilinear track, with no
detectable evidence of free diffusion in the rest of the nucleo-
plasm. Tracks are apparent in many paraformaldehyde fixed cells
(B), but become more elongated in nuclei swollen with hypotonic
solution (C). Two-color analysis shows the gene (green) is consis-
tently at one end of the much longer RNA track (red), as previ-
ously suggested (Lawrence et al., 1989) and recently shown (Mel-
cak et al., 2000). 
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analysis of components within an individual domain sug-
gest that they are far more complex structures (Johnson et
al., manuscript submitted for publication).
A very recent review in 
 
Science
 
 discusses some of this
work. It may be construed to convey that most key issues
are resolved and that it is now well established that factors
freely diffuse in nucleoplasmic space, and concentrate at
sites of function (Lewis and Tollervey, 2000). However, we
hope our discussion of the studies by Kruhlak et al. (2000)
and Phair and Misteli (2000) makes clear that many com-
pelling questions remain and that explanations should not
be expected to be simple. Rather, common ground may
only be found in the complexity of nuclear structure.
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